Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells-Reference-Cited by-同舟云学术

Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells

Published:2017-10-31 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Carnevale Gianluca,Carpino Guido,Cardinale Vincenzo,Pisciotta Alessandra,Riccio Massimo,Bertoni Laura,Gibellini Lara,De Biasi Sara,Nevi Lorenzo^ORCID,Costantini Daniele,Overi Diletta^ORCID,Cossarizza Andrea,de Pol Anto,Gaudio Eugenio,Alvaro Domenico

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14838-3.pdf

Reference33 articles.

1. Banales, J. M. et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261–280 (2016).

2. Nakanuma, Y. et al. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol. 2, 419–427 (2011).

3. Cardinale, V. et al. Profiles of cancer stem cell subpopulations in cholangiocarcinomas. Am J Pathol. 185, 1724–1739 (2015).

4. Oikawa, T. et al. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology. 57, 1469–1483 (2013).

5. Massani, M. et al. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions. Oncol Rep. 30, 1143–1148 (2013).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma;Clinics and Research in Hepatology and Gastroenterology;2024-10

2. Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies;Biomarkers in Medicine;2024-08-15

3. Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-08

4. Initial clinical outcomes of robotic resection for perihilar cholangiocarcinoma: Is it safe and effective?;Journal of Surgical Oncology;2024-05-13

5. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review);International Journal of Oncology;2023-10-27